Advances in Neonatal Hematology and Hyperbilirubinemia Management
Red Blood Cell Transfusions and Risk of Necrotizing Enterocolitis: A Hazard Period Analysis of the TOP Trial
Saturday, April 23, 2022
9:00 AM – 9:15 AM US MT
Location: Convention Center: Mile High Ballroom 3AB
CE: Enduring CME: 0.25
Publication Number: 1010.5
Ariel A. Salas, University of Alabama School of Medicine, Birmingham, AL, United States; Elizabeth R. Gunn, University of Alabama at Birmingham, Birmingham, AL, United States; Waldemar A. Carlo, University of Alabama at Birmingham, Birmingham, AL, United States; Edward F. Bell, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA, United States; Abhik Das, RTI International, North Potomac, MD, United States; Cassandra Josephson, Emory University School of Medicine, Atlanta, GA, United States; Ravi M. Patel, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Sylvia Tan, RTI International, WASHINGTON, DC, United States; Haresh Kirpalani, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; NICHD Neonatal Research Network, NICHD, Bethesda, MD, United States
Presenting Author(s)
Ariel A. Salas, MD, MSPH
Associate Professor University of Alabama School of Medicine Birmingham, Alabama, United States
Participants should be aware of the following financial/non-financial relationships:
Ariel A. Salas, MD, MSPH: ● Lockwood Group LLC (Currently Ongoing) (Products/Services: Advisory Committee). ● UAB (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
Elizabeth R. Gunn, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Waldemar A. Carlo, MD: ● Mednax (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Edward F. Bell, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Abhik Das, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Cassandra Josephson, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ravi M. Patel, MD, MSc: ● Infant Bacterial Therapeutics / Premier Research (Currently Ongoing) (Products/Services: Consultant).
Sylvia Tan, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Haresh Kirpalani, BM; MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
NICHD Neonatal Research Network: I do not have any relevant financial / non-financial relationships with any proprietary interests.